Microdosing as an Entry Point or Exit Strategy Chris Michaelis, DO, owner of Luminus Aesthetics, said microdosing often serves as an entry point or an exit strategy, depending on the patient
Protein shakes made with ingredients like whey, casein, or soy can also encourage GLP-1 secretion
All therapeutic applications remain investigational, and long-term human safety data are absent from the published literature
BAT activation may help improve metabolic issues such as high blood sugar and abnormal lipid levels, suggesting it could be a useful therapeutic target for obesity and related metabolic disorders [24]
P = 0.59)
We need long-term follow-up data to confirm the promising roles of IBAT in changing the natural course of PFIC disease, such as the delay in the need for LT due to pruritus or end-stage liver disease